Insiders · Profile

Stuart Bryan

See Remarks at Fulcrum Therapeutics. Filing since 10 Aug 2021. CIK 0001619846

Company
Date
Role
Action
Shares
Amount
Of holding
11 Aug 2021
See Remarks
Sold, plan not stated
28,000
$665.00K
100%
10 Aug 2021
See Remarks
Sold, plan not stated
32,000
$560.00K
100%
2 decisions on file.